Literature DB >> 32255851

Cytotoxic Effect of Prodigiosin, Natural Red Pigment, Isolated from Serratia marcescens UFPEDA 398.

J C L Lapenda1, V P Alves2, M L Adam3, M D Rodrigues1, S C Nascimento1.   

Abstract

Prodigiosin is a secondary metabolite, with red pigmentation, produced by Serratia marcescens. Red pigment is a natural alkaloid whose chemical structure has three pyrrole rings. Prodigiosin has been described for several biological activities, including antitumor, inducing apotosis in T and B lymphocytes. This work aimed to evaluate the cytotoxic activity of prodigiosin in NCHI-292, HEp-2, MCF-7 and HL-60 tumor cell lines. The red pigment was isolated from Serratia marcescens UFPEDA 398 biomass whose fractions were previously separated by column chromatography, purified, identified and further characterized by GC-MS and compared with the computerized library of m/z values. The pigment corresponded to prodigiosin with maximum absorption at 534 nm, molecular weight 323 and structural formula C20H25N3O. During the prodigiosin purification process a purple absorbance fraction at 272.65 nm was also observed. Significant cytotoxic effects of prodigiosin were evidenced for NCHI-292, Hep-2, MCF-7 and HL-60 tumor cell lines. The isolated purple fraction had no cytotoxic effect (IC50 11.3 µg/mL) when compared to prodigiosin (IC50 3.4 µg/mL) for the tumor cell lines studied. The MCF-7 strain was slightly more pigment resistant (IC50 5.1 µg/mL). Therefore, further studies will be needed to elucidate the antitumor mechanisms of prodigiosin action against tumor strains from flow cytometry tests. However, although these data are preliminary, it was evidenced that prodigiosin showed cytotoxic activity in tumor cell lines suggesting promising antitumor properties. In this sense, future studies on the cytotoxic and genotoxic effects of prodigiosin produced by S. marcecsens UFPEDA 398 are suggested. © Association of Microbiologists of India 2020.

Entities:  

Keywords:  Cytotoxicity; Genotoxicity; Prodigiosin; Serratia marcescens

Year:  2020        PMID: 32255851      PMCID: PMC7105545          DOI: 10.1007/s12088-020-00859-6

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  31 in total

1.  Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines.

Authors:  Roser Francisco; Ricardo Pérez-Tomás; Pepita Gimènez-Bonafé; Vanessa Soto-Cerrato; Pol Giménez-Xavier; Santiago Ambrosio
Journal:  Eur J Pharmacol       Date:  2007-07-04       Impact factor: 4.432

2.  Prodigiosin down-regulates SKP2 to induce p27(KIP1) stabilization and antiproliferation in human lung adenocarcinoma cells.

Authors:  Hsin-Ying Hsieh; Jeng-Jer Shieh; Chun-Jung Chen; Mu-Yun Pan; Shu-Yi Yang; Shin-Chang Lin; Jo-Shu Chang; Alan Yueh-Luen Lee; Chia-Che Chang
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 3.  Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.

Authors:  R A Manderville
Journal:  Curr Med Chem Anticancer Agents       Date:  2001-08

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species.

Authors:  B Bellosillo; N Villamor; A López-Guillermo; S Marcé; J Esteve; E Campo; D Colomer; E Montserrat
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  [Pigmentation of Serratia marcescens and spectral properties of prodigiosin].

Authors:  I N Andreeva; T I Ogorodnikova
Journal:  Mikrobiologiia       Date:  2015 Jan-Feb

Review 7.  The prodigiosins: a new family of anticancer drugs.

Authors:  Beatriz Montaner; Ricardo Pérez-Tomás
Journal:  Curr Cancer Drug Targets       Date:  2003-02       Impact factor: 3.428

8.  Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.

Authors:  G Koopman; C P Reutelingsperger; G A Kuijten; R M Keehnen; S T Pals; M H van Oers
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

9.  Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell lines.

Authors:  Chien-Hsing Lu; Shin-Chang Lin; Shu-Yi Yang; Mu-Yun Pan; Yun-Wei Lin; Chun-Yi Hsu; Yu-Hong Wei; Jo-Shu Chang; Chia-Che Chang
Journal:  Toxicol Lett       Date:  2012-05-10       Impact factor: 4.372

10.  Genomic blueprint of Hahella chejuensis, a marine microbe producing an algicidal agent.

Authors:  Haeyoung Jeong; Joung Han Yim; Choonghwan Lee; Sang-Haeng Choi; Yon Kyoung Park; Sung Ho Yoon; Cheol-Goo Hur; Ho-Young Kang; Dockyu Kim; Hyun Hee Lee; Kyun Hyang Park; Seung-Hwan Park; Hong-Seog Park; Hong Kum Lee; Tae Kwang Oh; Jihyun F Kim
Journal:  Nucleic Acids Res       Date:  2005-12-13       Impact factor: 16.971

View more
  4 in total

1.  Prodigiosin-Functionalized Probiotic Ghosts as a Bioinspired Combination Against Colorectal Cancer Cells.

Authors:  Nessrin Saleh; Hoda E Mahmoud; Hoda Eltaher; Maged Helmy; Labiba El-Khordagui; Ahmed A Hussein
Journal:  Probiotics Antimicrob Proteins       Date:  2022-08-28       Impact factor: 5.265

2.  Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines.

Authors:  Long Cheng; Yan Wang; Jiawei Wang; Haibo Qin; Guangbiao Zhu; Lingsong Tao
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

Review 3.  Recent Advances in Prodigiosin as a Bioactive Compound in Nanocomposite Applications.

Authors:  Rafael G Araújo; Natalia Rodríguez Zavala; Carlos Castillo-Zacarías; Mario E Barocio; Enrique Hidalgo-Vázquez; Lizeth Parra-Arroyo; Jesús Alfredo Rodríguez-Hernández; María Adriana Martínez-Prado; Juan Eduardo Sosa-Hernández; Manuel Martínez-Ruiz; Wei Ning Chen; Damià Barceló; Hafiz M N Iqbal; Roberto Parra-Saldívar
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

4.  Butylcycloheptylprodigiosin and undecylprodigiosin are potential photosensitizer candidates for photodynamic cancer therapy.

Authors:  Zahra Arshadi; Sayedeh Azimeh Hosseini; Daryoush Fatehi; Seyed Abbas Mirzaei; Fatemeh Elahian
Journal:  Mol Biol Rep       Date:  2021-07-30       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.